Funding

TRR
Open Access funding enabled and organized by Projekt DEAL. The study was supported by a grant from the German Research Foundation (DFG: EXC 257) and was in part supported by the German Research Foundation (DFG: Project-ID 402170461 – TRR 265; (PP, AG, AH, AB)). OG received consulting fees from Takeda and won a grant from the Novartis, outside the submitted work.